Postdoctoral Researcher in Developmental Epigenetics: The Gdula Lab at the Institute of Molecular Biology and Biotechnology, Adam Mickiewicz University (AMU), is seeking a highly motivated Postdoctoral Researcher to investigate 3D genome re-organization during induced senescence in pancreatic cancer as part of a collaborative NCN/DFG OPUS-LAP project.
Designation
Postdoctoral Researcher
Location
Adam Mickiewicz University, Poznań, Poland
| Research Area | Details |
|---|---|
| Project Title | 3D genome re-organization during induced senescence in pancreatic cancer |
| Collaboration | In collaboration with the University of Göttingen, Germany |
| Funding | National Science Centre, full-time for three years |
| Salary | Approximately 112,000 PLN p.a (brutto: 8,987 PLN/month + 13th salary) |
Eligibility/Qualification
- PhD in Molecular Biology, Genetics, or a related field
- Strong skill set in standard Molecular Biology/Biochemistry techniques
- Experience in genomic experiments (RNA-seq, ChIP-seq, WGBS or similar)
- At least one peer-reviewed first author publication in a relevant subject (e.g., epigenetics) in high-impact journals
- Evidence of independent thinking and project leadership capabilities
- High level of communication and interpersonal skills
- Fluency in English
Job Description
As a Postdoctoral Researcher, you will:
- Lead an independent research project and conduct molecular biology, cell culture experiments, and computational analysis of NGS/long-read Nanopore data.
- Analyze epigenomic changes in pancreatic organoid cultures induced by interference with HMGB2 interactors.
- Utilize various genomic techniques to profile chromatin interactions and heterochromatin distributions.
- Present research findings at group meetings, internal seminars, and conferences.
- Contribute to manuscript preparation.
How to Apply
Interested candidates should send the following documents as a single PDF file to michal.gdula@amu.edu.pl:
- Cover letter
- CV
- Contacts of three referees
Last Date for Apply
March 20, 2026
Start Date
May 1, 2026
Join us in pioneering research that could significantly impact our understanding of pancreatic cancer and its treatment!
